Cerba Research

Executive Summary

Cerba Research is a Belgium-based global specialty laboratory services provider supporting clinical trials for life science companies. Founded in 2018, the company leverages over 50 years of cumulative scientific expertise to offer integrated central and specialty lab solutions, with a particular focus on complex assays and biomarker analysis. Its mission is to transform scientific discoveries into breakthrough therapies through precise, scalable laboratory services. Operating in the diagnostics and infectious disease categories, Cerba Research serves as a critical partner in the drug development pipeline, enabling sponsors to accelerate clinical trials with reliable, regulatory-compliant data. The company's private, pre-clinical stage positioning suggests it is well-placed to capture growing demand for specialized lab services driven by increasing clinical trial complexity and biomarker-driven therapies. With a strong foothold in Europe and potential for international expansion, Cerba Research is poised for steady growth, though its private status limits visibility into financial performance.

Upcoming Catalysts (preview)

• Q3 2026New biomarker assay launch for oncology or infectious disease70% success
• Q4 2026Strategic partnership with a top 20 pharma company for central lab services50% success
• Q1 2027Expansion into U.S. market via acquisition or new laboratory facility40% success